Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Zamuner

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2010
Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humansCecilia Renzulli, Mike Nash, Mark Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 6, 2015
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static cultureKevin R Page, Enrica Mezzalana, Alexander J MacDonald, et al.
Journal of Psychopharmacology (Oxford, England)|July 7, 2011
Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonistPaolo Bettica, Gianluca Nucci, Caroline Pyke, et al.
Angewandte Chemie (International Ed. in English)|August 12, 2021
Light-Switchable BuffersCesare Berton, Daniel Maria Busiello, Stefano Zamuner, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
Data-driven large-scale genomic analysis reveals an intricate phylogenetic and functional landscape in J-domain proteinsDuccio Malinverni, Stefano Zamuner, Mathieu E Rebeaud, et al.
The AAPS Journal|June 22, 2011
Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysisRoberto Bizzotto, Stefano Zamuner, Enrica Mezzalana, et al.
Science Advances|October 6, 2021
Relief of ParB autoinhibition by <i>parS</i> DNA catalysis and recycling of ParB by CTP hydrolysis promote bacterial centromere assemblyHammam Antar, Young-Min Soh, Stefano Zamuner, et al.
Chemical Science|June 14, 2021
Thermodynamics and kinetics of protonated merocyanine photoacids in waterCesare Berton, Daniel Maria Busiello, Stefano Zamuner, et al.
British Journal of Clinical Pharmacology|September 16, 2010
Effect of single and repeat doses of casopitant on the pharmacokinetics of CYP450 3A4 substrates midazolam and nifedipineStefano Zamuner, Brendan M Johnson, Sabrina Pagliarusco, et al.
British Journal of Clinical Pharmacology|June 15, 2018
In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibodyJuliet Reid, Stefano Zamuner, Ken Edwards, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2010
Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humansCecilia Renzulli, Mike Nash, Mark Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 6, 2015
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static cultureKevin R Page, Enrica Mezzalana, Alexander J MacDonald, et al.
Journal of Psychopharmacology (Oxford, England)|July 7, 2011
Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonistPaolo Bettica, Gianluca Nucci, Caroline Pyke, et al.
Angewandte Chemie (International Ed. in English)|August 12, 2021
Light-Switchable BuffersCesare Berton, Daniel Maria Busiello, Stefano Zamuner, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
Data-driven large-scale genomic analysis reveals an intricate phylogenetic and functional landscape in J-domain proteinsDuccio Malinverni, Stefano Zamuner, Mathieu E Rebeaud, et al.
The AAPS Journal|June 22, 2011
Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysisRoberto Bizzotto, Stefano Zamuner, Enrica Mezzalana, et al.
Science Advances|October 6, 2021
Relief of ParB autoinhibition by <i>parS</i> DNA catalysis and recycling of ParB by CTP hydrolysis promote bacterial centromere assemblyHammam Antar, Young-Min Soh, Stefano Zamuner, et al.
Chemical Science|June 14, 2021
Thermodynamics and kinetics of protonated merocyanine photoacids in waterCesare Berton, Daniel Maria Busiello, Stefano Zamuner, et al.
British Journal of Clinical Pharmacology|September 16, 2010
Effect of single and repeat doses of casopitant on the pharmacokinetics of CYP450 3A4 substrates midazolam and nifedipineStefano Zamuner, Brendan M Johnson, Sabrina Pagliarusco, et al.
British Journal of Clinical Pharmacology|June 15, 2018
In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibodyJuliet Reid, Stefano Zamuner, Ken Edwards, et al.
Pageof 5